In breast cancer cells, overexpression of MIR539 inhibited the proliferation and promoted apoptosis of breast cancer cells, suppressed EMT, and sensitized cells to cisplatin treatment (Cai et al., 2020). Here, MIR539 is linked to breast cancer.